Substance P in polymicrobial sepsis: Molecular fingerprint of lung injury in preprotachykinin-A-/- mice

Molecular Medicine

Volumn 16, Issue 5-6, 2010, Pages 188-198

  Hegde, Akhil ^a,b   Tamizhselvi, Ramasamy ^a   Manikandan, Jayapal ^c   Melendez, Alirio J ^c   Moochhala, Shabbir M ^a,d   Bhatia, Madhav ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d DSO NATIONAL LABORATORIES   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PREPROTACHYKININ A; SUBSTANCE P; TACHYKININ; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENE EXPRESSION PROFILING; IMMUNOMODULATION; INFLAMMATION; LUNG INJURY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEPSIS; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; BACTEREMIA; CHEMOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LUNG DISEASES; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TACHYKININS;

EID: 77951942383     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00166     Document Type: Article

References (34)

1. Ashare AL, et al. (2005) Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am. J. Physiol. Lung Cell Mol. Physiol. 288:L633-40
2. Reddy RC, Chen GH, Tekchandani PK, Standiford TJ. (2001) Sepsis-induced immunosuppression: from bad to worse. Immunol. Res. 24:273-87
3. Van der Poll T, Deventer SJ. (1999) Cytokines and anticytokines in the pathogenesis of sepsis. Infect. Dis. Clin. North Am. 13:413-26
4. Okazaki Y, Matsukawa A. (2009) Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis. Recent Pat. Inflamm. Allergy Drug Discov. 3:26-32
5. Hotchkiss RS, Karl IE. (2003) The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138-50
6. Remick DG. (2007) Pathophysiology of sepsis. Am. J. Pathol. 170:1435-44
7. Sriskandan S, Altmann DM. (2008) The immunology of sepsis. J. Pathol. 214:211-23
8. Marshall JC, et al. (2003) Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit. Care Med. 31:1560-67
9. Puneet P, et al. (2006) Preprotachykinin-A gene products are key mediators of lung injury in polymicrobial sepsis. J. Immunol. 176:3813-20
10. Ng SW, Zhang H, Hegde A, Bhatia M. (2008) Role of preprotachykinin-A gene products on multiple organ injury in LPS-induced endotoxemia. J. Leukoc. Biol. 83:288-95
11. Schulze A, Downward J. (2001) Navigating gene expression using microarrays: a technology re-view. Nat. Cell Biol. 3:E190-5
12. Chung TP, et al. (2006) Molecular diagnostics in sepsis: from bedside to bench. J. Am. Coll. Surg. 203:585-98
13. Ayala A, Herdon CD, Lehman DL, Ayala CA, Chaudry IH. (1996) Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87:4261-75
14. Zhou M, Chaudry IH, Wang P. (2001) The small intestine is an important source of adrenomedullin release during polymicrobial sepsis. Am. J. Physiol. 281:R654-60
15. Hegde A, Zhang H, Moochhala SM, Bhatia M. (2007) Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis. J. Leukoc. Biol. 82:678-85
16. Brazma A, et al. (2001) Minimum information about a microarray experiment (MIAME)-toward stan-dards for microarray data. Nat. Genet. 29:365-71
17. Bhatia M, Slavin J, Cao Y, Basbaum AI, Neoptolemos JP. (2003) Preprotachykinin-A gene deletion protects mice against acute pancreatitis and associated lung injury. Am. J. Physiol. 284:G830-36
18. Salkowski CA, Detore G, Franks A, Falk MC, Vogel SN. (1998) Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis- induced cytokine and chemokine expression and neutrophil infiltration. Infect. Immun. 66:3569-78
19. Osuchowski MF, Welch K, Siddiqui J, Remick DG. (2006) Circulating cytokine/inhibitor profiles re-shape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177:1967-74
20. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL. (1997) Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruit-ment and mortality. Infect. Immun. 65:3847-51
21. Ness TL, et al. (2004) CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis. J. Immunol. 173:6938-48
22. Matsukawa A, et al. (2000) Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response. J. Immunol. 164:5362-8
23. Ness TL, Hogaboam CM, Strieter RM, Kunkel SL. (2003) Immunomodulatory role of CXCR2 during experimental septic peritonitis. J. Immunol. 171:3775-84
24. Takahashi H, et al. (2002) An essential role of macrophage inflammatory protein 1a/CCL3 on the expression of host's innate immunities against infectious complications. J. Leukoc. Biol. 72:1190-7
25. Yang D, et al. (2003) Many chemokines including CCL20/MIP-3a display antimicrobial activity. J. Leukoc. Biol. 74:448-55
26. Matsukawa A, et al. (2000) Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response. J. Immunol. 164:5362-8
27. Kato T, et al. (1995) Interleukin 10 reduces mortality from severe peritonitis in mice. Antimicrob. Agents Chemother. 39:1336-40
28. Goldbach-Mansky R, et al. (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N. Engl. J. Med. 355:581-92
29. Zanetti M. (2004) Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75:39-48
30. Gueders MM, et al. (2005) Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation. J. Immunol. 175:2589-97
31. Grimm T, et al. (2006) Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J. Inflamm. (Lond.) 3:1
32. Cinel I, Opal SM. (2009) Molecular biology of inflammation and sepsis: a primer. Crit. Care Med. 37:291-304
33. Chen Y, Voegeli TS, Liu PP, Noble EG, Currie RW. (2007) Heat shock paradox and a new role of heat shock proteins and their receptors as anti-inflammation targets. Inflamm. Allergy Drug Tar- gets 6:91-100
34. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. (2003) Cytokine cascade in sepsis. Scand. J. Infect. Dis. 35:535-44.